TY - JOUR
T1 - Polymeric Nanogels with Tailorable Degradation Behavior
AU - Chen, Yinan
AU - van Steenbergen, Mies J.
AU - Li, Dandan
AU - van de Dikkenberg, Joep B.
AU - Lammers, Twan Gerardus Gertudis Maria
AU - van Nostrum, Cornelis F.
AU - Metselaar, Josbert Maarten
AU - Hennink, Wim E.
PY - 2016
Y1 - 2016
N2 - The aim of this study is to design a polymeric nanogel system with tailorable degradation behavior. To this end, hydroxyethyl methacrylate-oligoglycolates-derivatized poly(hydroxypropyl methacrylamide) (pHPMAm-Gly-HEMA) and hydroxyethyl methacrylamide-oligoglycolates-derivatized poly(hydroxyethyl methacrylamide) (pHEMAm-Gly-HEMAm) are synthesized and characterized. pHEMAm-Gly-HEMAm shows faster hydrolysis rates of both carbonate and glycolate esters than the same ester groups of pHPMAm-Gly-HEMA. pHEMAm-Gly-HEMAm nanogels have tailorable degradation kinetics from 24 h to more than 4 d by varying their crosslink densities. It is shown that the release of a loaded macromolecular model drug is controlled by degradation of nanogels. The nanogels show similar cytocompatibility as PLGA nanoparticles and are therefore considered to be attractive systems for drug delivery.
AB - The aim of this study is to design a polymeric nanogel system with tailorable degradation behavior. To this end, hydroxyethyl methacrylate-oligoglycolates-derivatized poly(hydroxypropyl methacrylamide) (pHPMAm-Gly-HEMA) and hydroxyethyl methacrylamide-oligoglycolates-derivatized poly(hydroxyethyl methacrylamide) (pHEMAm-Gly-HEMAm) are synthesized and characterized. pHEMAm-Gly-HEMAm shows faster hydrolysis rates of both carbonate and glycolate esters than the same ester groups of pHPMAm-Gly-HEMA. pHEMAm-Gly-HEMAm nanogels have tailorable degradation kinetics from 24 h to more than 4 d by varying their crosslink densities. It is shown that the release of a loaded macromolecular model drug is controlled by degradation of nanogels. The nanogels show similar cytocompatibility as PLGA nanoparticles and are therefore considered to be attractive systems for drug delivery.
KW - METIS-321006
KW - IR-103533
U2 - 10.1002/mabi.201600031
DO - 10.1002/mabi.201600031
M3 - Article
VL - 16
SP - 1122
EP - 1137
JO - Macromolecular bioscience
JF - Macromolecular bioscience
SN - 1616-5187
IS - 8
ER -